Eli Lilly to speculate $1 billion on contract manufacturing in India

Eli Lilly and Company will make investments greater than $1 billion over the subsequent a number of years into new contract manufacturing in India. Additionally, the worldwide pharma main will set up a brand new manufacturing and high quality facility in Hyderabad.

The funding will additional strengthen the manufacturing and provide capabilities to help the corporate’s evolving portfolio, Eli Lilly stated on Monday (October 6, 2025). “We are making important investments to extend manufacturing and medication provide capability all over the world to assist guarantee sufferers have entry to the medicines they want,” stated Patrik Jonsson, government vice chairman and president, Lilly International, Eli Lilly and Company.

The proposed funding reaffirms the Eli Lilly’s confidence in India as a hub for functionality constructing inside the firm’s world community.

Working with trusted contract producers expands the corporate’s capabilities to ship life-changing medicines at higher scale, with high quality all the time on the core, he stated.

The firm stated the funding choice resonates with the Make in India agenda. Since 2020, Lilly has dedicated greater than $55 billion to construct, increase and purchase services within the U.S. and all over the world. These services and investments handle development from potential new medicines to deal with diabetes and weight problems, Alzheimer’s illness, most cancers and autoimmune situations and put together for medicines of the long run. This initiative displays Lilly’s intent to leverage India’s extremely expert expertise pool to help its world manufacturing development and ship medicines to sufferers worldwide, it stated in a launch.

Hub in Hyderabad

On the the brand new manufacturing and high quality facility in Hyderabad, a metropolis the place the corporate’s GCC opened in August, it stated the proposed facility might be a hub providing superior technical capabilities and oversight for Lilly’s contract manufacturing community throughout India. Recruitment will start instantly, with openings throughout roles reminiscent of engineers, chemists, analytical scientists, high quality management and assurance professionals and administration positions.

“Lilly’s continued enlargement in Hyderabad highlights the town’s emergence as a powerhouse in world healthcare innovation. From the current opening of its innovation and expertise website to a brand new manufacturing collaboration and the institution of a producing and high quality hub, Lilly is transferring swiftly to increase its presence in Telangana. The choice reinforcing the State’s place as a most popular vacation spot for cutting-edge healthcare investments,” Telangana Chief Minister A. Revanth Reddy stated.

The firm stated it has a longstanding presence in India, which features a business website in Gurugram and specialised websites in Bengaluru and Hyderabad that function essential hubs supporting world innovation.

Industries and IT Minister D. Sridhar Babu stated the corporate’s enlargement in Hyderabad is a testomony to Telangana’s dynamic industrial panorama and its rising affect in superior healthcare manufacturing. The State’s deal with technology-driven infrastructure and ease of doing enterprise continues to draw world leaders throughout sectors and lifesciences sector particularly has been on accelerated development.”